BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 31753003)

  • 21. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.
    Boeters DM; Mangnus L; Ajeganova S; Lindqvist E; Svensson B; Toes REM; Trouw LA; Huizinga TWJ; Berenbaum F; Morel J; Rantapää-Dahlqvist S; van der Helm-van Mil AHM
    Arthritis Res Ther; 2017 May; 19(1):115. PubMed ID: 28569212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between body mass index and anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis: results from a population-based case-control study.
    Wesley A; Bengtsson C; Elkan AC; Klareskog L; Alfredsson L; Wedrén S;
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):107-12. PubMed ID: 22674870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor.
    Ishikawa Y; Ikari K; Hashimoto M; Ohmura K; Tanaka M; Ito H; Taniguchi A; Yamanaka H; Mimori T; Terao C
    Ann Rheum Dis; 2019 Nov; 78(11):1480-1487. PubMed ID: 31427439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
    Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
    Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex Relationships of Smoking, HLA-DRB1 Genes, and Serologic Profiles in Patients With Early Rheumatoid Arthritis: Update From a Swedish Population-Based Case-Control Study.
    Hedström AK; Rönnelid J; Klareskog L; Alfredsson L
    Arthritis Rheumatol; 2019 Sep; 71(9):1504-1511. PubMed ID: 30742363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
    Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
    RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis.
    Che Rahim MJ; Wan Mohamad WM; Saddki N; Taib H; Wan Abhamid WZ; Wong KK; Wan Ghazali WS
    Malays J Pathol; 2019 Dec; 41(3):267-272. PubMed ID: 31901911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.
    Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F
    Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.
    Boer AC; Boonen A; van der Helm van Mil AHM
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):987-996. PubMed ID: 29266813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACPA Antibodies Titer at the Time of Rheumatoid Arthritis Diagnosis Is Not Associated with Disease Severity.
    Shpatz R; Braun-Moscovici Y; Balbir-Gurman A
    Isr Med Assoc J; 2021 Oct; 23(10):646-650. PubMed ID: 34672447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis.
    Joshua V; Hensvold AH; Reynisdottir G; Hansson M; Cornillet M; Nogueira L; Serre G; Nyren S; Karimi R; Eklund A; Sköld M; Grunewald J; Chatzidionysiou K; Catrina A
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis.
    Joo YB; Park YJ; Park KS; Kim KJ
    Clin Rheumatol; 2019 Sep; 38(9):2423-2432. PubMed ID: 31049760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry.
    Huang S; He X; Doyle TJ; Zaccardelli A; Marshall AA; Friedlander HM; Blaustein RB; Smith EA; Cui J; Iannaccone CK; Mahmoud TG; Weinblatt ME; Dellaripa PF; Shadick NA; Sparks JA
    Clin Rheumatol; 2019 Dec; 38(12):3401-3412. PubMed ID: 31410660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
    Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
    Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Hiwa R; Ikari K; Ohmura K; Nakabo S; Matsuo K; Saji H; Yurugi K; Miura Y; Maekawa T; Taniguchi A; Yamanaka H; Matsuda F; Mimori T; Terao C
    J Rheumatol; 2018 Apr; 45(4):470-480. PubMed ID: 29419463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort.
    Mouterde G; Rincheval N; Lukas C; Daien C; Saraux A; Dieudé P; Morel J; Combe B
    Arthritis Res Ther; 2019 Jun; 21(1):140. PubMed ID: 31171038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
    Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
    J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis.
    Shafrin J; Tebeka MG; Price K; Patel C; Michaud K
    J Manag Care Spec Pharm; 2018 Jan; 24(1):4-11. PubMed ID: 29290168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
    Murphy D; Mattey D; Hutchinson D
    PLoS One; 2017; 12(7):e0180655. PubMed ID: 28708862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
    Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
    J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.